Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Exclusion Criteria

• •Clinically significant health concerns
• •Regular use of alcohol within one month prior to Screening
• •Use of an investigational agent or device within 30 days prior to dosing or current participation in an investigational study
• •Recent use of illicit drugs
• •Use of more than two tobacco/nicotine containing or cannabis products per month within 6 months prior to drug administration (applicable only to Normal Healthy Volunteers)